 |
Previous Article | Next Article 
Volume 16, Number 9,
Issue of May 1, 1996
pp. 3045-3055
Copyright ©1996 Society for Neuroscience
Immunological Instability of Persistent Adenovirus Vectors in the
Brain: Peripheral Exposure to Vector Leads to Renewed Inflammation,
Reduced Gene Expression, and Demyelination
Received Dec. 14, 1995; revised Feb. 6, 1996; accepted Feb. 13, 1996.
Andrew P. Byrnes,
Robert E. MacLaren, and
Harry M. Charlton
Department of Human Anatomy, University of Oxford, Oxford OX1 3QX,
United Kingdom
Nonreplicating adenovirus vectors are being developed as vehicles
for the delivery of therapeutic genes in vivo. Whereas in
many organs an antiviral T cell response eliminates the vector and
damages local tissue, when adenovirus vectors are injected into the
brain the subsequent immune attack can be ineffective, allowing the
vector to persist.
In the present study, E1-deleted human adenovirus vectors were injected
into the caudate nucleus of rats. Two months later, expression of
protein from the vector was still evident and little inflammation was
seen. A subcutaneous injection of adenovirus vector at this time,
however, led within 2 weeks to severe mononuclear inflammation and
microglial activation in the caudate. This caused local demyelination
and a decrease in detectable protein expression from the vector.
Interestingly, intense microglial activation and numerous lymphocytes
and monocytes were also seen in brain areas containing neurons capable
of retrogradely transporting the adenovirus vector from the caudate.
Control experiments established that this inflammation in distant brain
areas was not a nonspecific consequence of degeneration.
These experiments demonstrate that although adenovirus vectors can
persist in the brain without causing chronic inflammation, they remain
the potential target of a damaging cell-mediated immune response
brought about by a subsequent peripheral exposure to vector. The
finding of lymphocytes in brain areas that project to the caudate
further shows that viral antigens that are retrogradely transported by
neurons can also be the target of a T cell attack.
Key words:
adenovirus;
neuroimmunology;
gene therapy;
viral vector;
demyelination;
microglia;
caudate
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Zirger, C. Barcia, C. Liu, M. Puntel, N. Mitchell, I. Campbell, M. Castro, and P. R. Lowenstein
Rapid Upregulation of Interferon-Regulated and Chemokine mRNAs upon Injection of 108 International Units, but Not Lower Doses, of Adenoviral Vectors into the Brain.
J. Virol.,
June 1, 2006;
80(11):
5655 - 5659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Barzon, M. Boscaro, and G. Palu
Endocrine Aspects of Cancer Gene Therapy
Endocr. Rev.,
February 1, 2004;
25(1):
1 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Simons, R. O. Bonow, N. A. Chronos, D. J. Cohen, F. J. Giordano, H. K. Hammond, R. J. Laham, W. Li, M. Pike, F. W. Sellke, et al.
Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus : An Expert Panel Summary
Circulation,
September 12, 2000;
102
(11):
e73 - e86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Thomas, G. Schiedner, S. Kochanek, M. G. Castro, and P. R. Löwenstein
Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases
PNAS,
June 6, 2000;
(2000)
120474397.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. S. Stein, A. Ghodsi, T. Derksen, and B. L. Davidson
Systemic and Central Nervous System Correction of Lysosomal Storage in Mucopolysaccharidosis Type VII Mice
J. Virol.,
April 1, 1999;
73(4):
3424 - 3429.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Morelli, A. Larregina, J Smith-Arica, R. Dewey, T. Southgate, B Ambar, A Fontana, M. Castro, and P. Lowenstein
Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity
J. Gen. Virol.,
March 1, 1999;
80(3):
571 - 583.
[Abstract]
|
 |
|

|
 |

|
 |
 
T. Cartmell, T. Southgate, G. S. Rees, M. G. Castro, P. R. Lowenstein, and G. N. Luheshi
Interleukin-1 Mediates a Rapid Inflammatory Response After Injection of Adenoviral Vectors into the Brain
J. Neurosci.,
February 15, 1999;
19(4):
1517 - 1523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bilang-Bleuel, F. Revah, P. Colin, I. Locquet, J.-J. Robert, J. Mallet, and P. Horellou
Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease
PNAS,
August 5, 1997;
94(16):
8818 - 8823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Thomas, G. Schiedner, S. Kochanek, M. G. Castro, and P. R. Lowenstein
Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic long-term neurological gene therapy for chronic diseases
PNAS,
June 20, 2000;
97(13):
7482 - 7487.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|